Gastroenteropancreatic neuroendocrine tumors

M Cives, JR Strosberg - CA: a cancer journal for clinicians, 2018 - Wiley Online Library
Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse
neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract …

Evaluation and management of neuroendocrine tumors of the pancreas

AT Scott, JR Howe - Surgical Clinics, 2019 - surgical.theclinics.com
Neuroendocrine tumors (NETs) are a diverse group of neoplasms arising from cells in the
diffuse neuroendocrine system. At least 17 different types of neuroendocrine cells are found …

A clinicopathologic and molecular update of pancreatic neuroendocrine neoplasms with a focus on the new World Health Organization classification

JM Fang, J Shi - Archives of pathology & laboratory …, 2019 - meridian.allenpress.com
Context.—According to the 2017 World Health Organization classification, pancreatic
neuroendocrine neoplasms (PanNENs) include a new category of pancreatic …

Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies

L Lee, T Ito, RT Jensen - Expert review of anticancer therapy, 2019 - Taylor & Francis
Introduction: Recent advances in diagnostic modalities and therapeutic agents have raised
the importance of prognostic factors in predicting overall survival, as well as predictive …

Multi-institutional development and external validation of a nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors

A Pulvirenti, AA Javed, L Landoni, NB Jamieson… - Annals of …, 2021 - journals.lww.com
Objective: To develop a nomogram estimating the probability of recurrence free at 5 years
after resection for localized grade 1 (G1)/grade 2 (G2) pancreatic neuroendocrine tumors …

Surgical management of pancreatic neuroendocrine tumors

ML Sulciner, TE Clancy - Cancers, 2023 - mdpi.com
Simple Summary This review, as part of a series of reviews on neuroendocrine tumors,
focuses on the particular management strategies for pancreatic neuroendocrine tumors …

Significant function and research progress of biomarkers in gastric cancer

DM Ye, G Xu, W Ma, Y Li, W Luo, Y Xiao… - Oncology …, 2020 - spandidos-publications.com
Gastric cancer is one of the most common gastrointestinal tumor types, and the incidence
and mortality rates are higher in men compared with women. Various studies have revealed …

Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective …

S Paiella, L Landoni, S Tebaldi, M Zuffante… - …, 2022 - karger.com
Introduction: The combined use of 68gallium (68Ga)-DOTA-peptides and 18fluorine-fluoro-2-
deoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) …

Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where?

G Marchegiani, L Landoni, S Andrianello… - …, 2019 - karger.com
Background/Aims: Pancreatic neuroendocrine tumors (pan-NENs) represent an increasingly
common indication for pancreatic resection, but there are few data regarding possible …

Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta …

V Andreasi, C Ricci, S Partelli, G Guarneri… - Journal of …, 2022 - Springer
Purpose Patients submitted to curative surgery for non-functioning pancreatic
neuroendocrine neoplasms (NF-PanNENs) exhibit a variable risk of disease relapse. Aims …